<DOC>
	<DOC>NCT01963442</DOC>
	<brief_summary>To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of treatment in terms of clinical efficacy, in adults admitted to emergency services for a non severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin treatment (3GC or A/AC).</brief_summary>
	<brief_title>Short Duration Treatment of Non-severe Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>beta-Lactams</mesh_term>
	<mesh_term>Lactams</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<criteria>Subject must be 18 years old or over. admitted three days before for Community Acquired Pneumonia (CAP) defined by at least one clinical sign of pneumonia (dyspnea, cough, mucopurulent sputum, crackling sound on lungs) associated with a temperature &gt;38°C on admission, and a new infiltrate consistent with pneumonia on chest xray, who responded favorably to 3 days of treatment with βlactams (third generation injectable cephalosporin or amoxicillinclavulanate) able to take oral medication. has given its informed consent. Creatinin &lt; 30ml/min History of jaundice / hepatic impairment associated with amoxicillin / clavulanic acid History of hypersensitivity to betalactam Presence of complications or severity of pneumonia (abscess , significant pleural effusion, severe chronic respiratory failure , septic shock, respiratory condition requiring the passage resuscitation). Known immunocompromised terrain ( asplenia , neutropenia, agammaglobulinemia , immunosuppressants, graft corticosteroids , myeloma , lymphoma, known HIV , sickle cell anemia , CHILD C cirrhosis). Antibiotic treatment exceeding 24 hours prior admission. Suspected atypical bacteria requiring combined antibiotics therapy .(Subjects who received a single dose of macrolides or fluoroquinolones emergency will not be excluded) . Legionella suspected on clinical, biological and radiological criteria . Subjects with clinical or epidemiological environment leading to suspect a healthcareassociated pneumonia with antibiotic resistant pathogen. Suspicion of pneumonia by aspiration. Intercurrent infection requiring antibiotic treatment. Pregnant women . Breastfeeding . Allergy to antibiotics in use. Life expectancy &lt;1 month . Subject without health insurance. Subjects without home adress</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>